The global Swine Vaccines market size is expected to be worth around US$ 6.5 billion by 2030, according to a new report by Vision Research Reports.
The global Swine Vaccines market size was valued at US$ 2.45 billion in 2020 and is anticipated to grow at a CAGR of 5.9% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 6.5 billion by 2030 |
Growth Rate | CAGR of 5.9% From 2021 to 2030 |
Largest Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Product, Type |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Merck Animal Health; Ceva; Zoetis; BoehringerIngelheim GmbH; Elanco; Indian Immunologicals Ltd.; BiogénesisBagó; Phibro Animal Health; KM Biologics; HIPRA |
Growth Factors
Increasing prevalence of diseases, a surge in the demand for animal protein, and growth in R&D expenditure for vaccines innovation are driving the market growth. Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.
Swine production is a key component of global food security, agricultural countries, and local & international business. Contagious diseases impact pig health and stability and productivity of the swine industry globally. Thus, the rising prevalence of diseases in swine is estimated to drive the market over the forecast years. Porcine Parvovirus (PPV) is a reproductive disease present in most pig farms globally. Porcine Reproductive and Respiratory Syndrome (PRRS) remains to be a highly prevalent disease in pig farms affecting economic losses through its adverse effects on reproduction and growth as well as by clinical illness.
By Product Analysis
The inactivated vaccines segment dominated the global market in 2020 with a revenue share of more than 38% in 2020. This is attributed to the easy availability, low cost, minimal risk of revert reaction of killed viruses, and new improvements by key players.
The recombinant vaccine segment is expected to exhibit the fastest CAGR from 2021 to 2028. These vaccines are anticipated to assist in achieving vaccination against several virus strains, as recombinants can carry numerous gene inserts.
By Type Analysis
The Porcine Circovirus type 2 (PCV2) dominated the global market with a revenue share of more than 14% in 2020. Transmission of PCV-2 may be by direct contact with an infected pig. PCV2 is the quickly mutating of all single-stranded DNA (ssDNA) viruses and thus, has a great mutation and recombination rate.
The foot & mouth disease segment is expected to witness the second-fastest CAGR over the forecast period. In swine, foot-and-mouth disease is an epidemic that has a substantial effect on food safety and animal husbandry.
By Regional Analysis
Asia Pacific accounted for the maximum revenue share of more than 46% in 2020 and is anticipated to register the fastest CAGR during the forecast period. Middle-income nations, especially Southeast Asian countries, consume greater amounts of meat and the meat consumption of pork is still on the rise.
North America held a significant revenue share in 2020. The presence of well-established veterinary healthcare infrastructure, increased demand for animal protein, highly organized farming structure, and rising expenditure on animal health is attributed to the region’s growth.
Key Players
Merck Animal Health
Ceva
Zoetis
Boehringer Ingelheim GmbH
Elanco
Indian Immunologicals Ltd.
BiogénesisBagó
Phibro Animal Health
KM Biologics
HIPRA
Market Segmentation
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
ActinobacillusPleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
Saudi Arabia
South Africa
The Swine Vaccines market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Swine Vaccines market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Swine Vaccines market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Swine Vaccines market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Swine Vaccines market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Swine Vaccines capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Swine Vaccines by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Swine Vaccines market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Swine Vaccines market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Swine Vaccines market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Swine Vaccines industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Swine Vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Swine Vaccines market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Swine Vaccines market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Swine Vaccines market. These factors have benefited the growth of the global market for Swine Vaccines. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Swine Vaccines. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Swine Vaccines are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Swine Vaccines Market, By Type
7.1. Swine Vaccines Market, by Type, 2021-2030
7.1.1. Swine Influenza
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Classical Swine Fever
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Porcine Parvovirus
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Porcine Circovirus Type 2
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. M.Hyo
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. ActinobacillusPleuropneumonia
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. PRRS
7.1.7.1. Market Revenue and Forecast (2017-2030)
7.1.8. Foot & Mouth Disease
7.1.8.1. Market Revenue and Forecast (2017-2030)
7.1.9. Pseudorabies
7.1.9.1. Market Revenue and Forecast (2017-2030)
7.1.10. PEDV
7.1.10.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Swine Vaccines Market, By Product
8.1. Swine Vaccines Market, by Product, 2021-2030
8.1.1. Attenuated Live Vaccines
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Inactivated Vaccines
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Subunit Vaccines
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. DNA Vaccines
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Recombinant Vaccines
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Swine Vaccines Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Type (2017-2030)
9.1.2. Market Revenue and Forecast, by Product (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Product (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Product (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type (2017-2030)
9.2.2. Market Revenue and Forecast, by Product (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Product (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Product (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Product (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type (2017-2030)
9.3.2. Market Revenue and Forecast, by Product (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Product (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Product (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Product (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type (2017-2030)
9.4.2. Market Revenue and Forecast, by Product (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Product (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Product (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Product (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type (2017-2030)
9.5.2. Market Revenue and Forecast, by Product (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Product (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Product (2017-2030)
Chapter 10. Company Profiles
10.1. Merck Animal Health
10.1.1. Company Overview
10.1.2. Type Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Ceva
10.2.1. Company Overview
10.2.2. Type Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Zoetis
10.3.1. Company Overview
10.3.2. Type Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Boehringer Ingelheim GmbH
10.4.1. Company Overview
10.4.2. Type Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Elanco
10.5.1. Company Overview
10.5.2. Type Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Indian Immunologicals Ltd.
10.6.1. Company Overview
10.6.2. Type Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. BiogénesisBagó
10.7.1. Company Overview
10.7.2. Type Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Phibro Animal Health
10.8.1. Company Overview
10.8.2. Type Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. KM Biologics
10.9.1. Company Overview
10.9.2. Type Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. HIPRA
10.10.1. Company Overview
10.10.2. Type Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms